Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca2+ signaling

被引:33
|
作者
Zhang, Yan-Ping [1 ,2 ]
Wang, Wei-Li [1 ]
Liu, Jian [2 ]
Li, Wen-Bin [1 ]
Bai, Lin-Lin [2 ]
Yuan, Ya-Dong [2 ]
Song, Shu-Xia [3 ]
机构
[1] Hebei Med Univ, Dept Pathophysiol, Shijiazhuang 050017, Peoples R China
[2] Hebei Med Univ, Hosp 2, Dept Respirat, Shijiazhuang 050000, Peoples R China
[3] Hebei Med Univ, Dept Immunol, Shijiazhuang 050017, Peoples R China
关键词
Pulmonary fibrosis; Plasminogen activator inhibitor-1; Fibroblast; Proliferation; Apoptosis; Calcium ion; INDUCED LUNG FIBROSIS; SMOOTH-MUSCLE-CELLS; EXPRESSION; TYPE-1; SUPPRESSION; UROKINASE; SIRNA; MICE;
D O I
10.1016/j.thromres.2012.09.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Our previous investigation demonstrated that plasminogen activator inhibitor-1 (PAI-1) siRNA ameliorated bleomycin (BLM)-induced rat lung fibrosis. The present study was undertaken to explore the effect and the mechanism of PAI-1 siRNA and plasmid pcDNA on the proliferation and apoptosis of cultured fibroblasts from BLM-induced fibrotic lung tissues. Materials and Methods: The fibroblasts from BLM-induced fibrotic lung tissue were isolated and transfected using PAI-1 siRNA and plasmid pcDNA-PAI-1. The techniques of real time RT-PCR and/or western blot were used to determine the expression of PAI-1, alpha-smooth muscle actin (alpha-SMA) (real time RT-PCR only), collagen type-1 and type-3 (real time RT-PCR only), and the levels of caspase-3, ERK and AKT signal molecules. The proliferation of fibroblasts was measured by cell cycle with flow cytometry. The intracellular concentration of Ca2+ was examined by confocal laser microscopy. Results: PAI-1 siRNA downregulated the PAI-1 mRNA expression by 70%+/- 7% at 24 h and protein expression by 73.5%+/- 10% and 42%+/- 3% at 48 h and 72 h compared to Non-specific siRNA group. Flow cytometry showed that the fibroblasts at the G(2)M + S phase were significantly reduced by 20.56 +/- 1.03% after transfecting PAI-1 siRNA and were significantly increased by 43.8 +/- 1.21% after transfecting plasmid pcDNA-PAI-1. The mRNA expressions of alpha-SMA, collagen type-1and type-3 were downregulated after transfecting the PAI-1 siRNA, while upregulated after the transfection of pcDNA-PAI-1. PAI-1 siRNA increased the level of caspase-3, inhibited the expressions of p-ERK and p-AKT protein molecules, while the pcDNA-PAI-1 transfection showed a reversal effect on these expressions. Intracellular Ca2+ concentration was decreased after transfecting PAI-1 siRNA, whereas increased after transfecting pcDNA-PAI-1. Conclusion: PAI-1 promotes the proliferation, transforming into myofibroblasts, collagen synthesis, and inhibits apoptosis of pulmonary fibroblasts by activating Ca2+, ERK and AKT signaling pathway. Decreasing PAI-1 expression is an available strategy in inhibiting the progression of pulmonary fibrosis. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 50 条
  • [1] The sGC activator inhibits the proliferation and migration, promotes the apoptosis of human pulmonary arterial smooth muscle cells via the up regulation of plasminogen activator inhibitor-2
    Zhang, Shuai
    Zou, Lihui
    Yang, Ting
    Yang, Yuanhua
    Zhai, Zherzguo
    Xiao, Fei
    Wang, Chen
    EXPERIMENTAL CELL RESEARCH, 2015, 332 (02) : 278 - 287
  • [2] Recombinant Plasminogen Activator Inhibitor-1 Inhibits Intimal Hyperplasia
    Wu, Jianbo
    Peng, Lin
    McMahon, Grainne A.
    Lawrence, Daniel A.
    Fay, William P.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (10) : 1565 - U403
  • [3] Plasminogen Activator Inhibitor-1 Suppresses Profibrotic Responses in Fibroblasts from Fibrotic Lungs
    Marudamuthu, Amarnath S.
    Shetty, Shwetha K.
    Bhandary, Yashodhar P.
    Karandashova, Sophia
    Thompson, Michael
    Sathish, Venkatachalenn
    Florova, Galina
    Hogan, Taryn B.
    Pabelick, Christina M.
    Prakash, Y. S.
    Tsukasaki, Yoshikazu
    Fu, Jian
    Ikebe, Mitsuo
    Idell, Steven
    Shetty, Sreerama
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (15) : 9428 - 9441
  • [4] Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer
    Kubala, Marta Helena
    Punj, Vasu
    Placencio-Hickok, Veronica Rae
    Fang, Hua
    Fernandez, G. Esteban
    Sposto, Richard
    DeClerck, Yves Albert
    CELL REPORTS, 2018, 25 (08): : 2177 - +
  • [5] Plasminogen activator inhibitor-1: The double-edged sword in apoptosis
    Balsara, Rashna D.
    Ploplis, Victoria A.
    THROMBOSIS AND HAEMOSTASIS, 2008, 100 (06) : 1029 - 1036
  • [6] microRNA-10b promotes the apoptosis of bovine ovarian granulosa cells by targeting plasminogen activator inhibitor-1
    Guo, Lewei
    Huang, Qixuan
    Zhao, Jing
    Liu, Hongyu
    Lu, Wenfa
    Wang, Jun
    THERIOGENOLOGY, 2021, 176 : 206 - 216
  • [7] Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling
    Zhang, Shuai
    Wang, Jing
    Qi, Xianmei
    Tao, Xincao
    Xie, Wanmu
    Wan, Jun
    Shen, Ying H.
    Zhai, Zhenguo
    EXPERIMENTAL CELL RESEARCH, 2021, 398 (01)
  • [8] Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential
    Brodsky, SV
    Malinowski, K
    Golightly, M
    Jesty, J
    Goligorsky, MS
    CIRCULATION, 2002, 106 (18) : 2372 - 2378
  • [9] Plasminogen Activator Inhibitor-1 Promotes Neutrophil Infiltration and Tissue Injury on Ischemia-Reperfusion
    Praetner, Marc
    Zuchtriegel, Gabriele
    Holzer, Martin
    Uhl, Bernd
    Schaubaecher, Johanna
    Mittmann, Laura
    Fabritius, Matthias
    Fuerst, Robert
    Zahler, Stefan
    Funken, Dominik
    Lerchenberger, Maximilian
    Khandoga, Andrej
    Kanse, Sandip
    Lauber, Kirsten
    Krombach, Fritz
    Reichel, Christoph A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (04) : 829 - 842
  • [10] Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination
    Nakatsuka, Erika
    Sawada, Kenjiro
    Nakamura, Koji
    Yoshimura, Akihito
    Kinose, Yasuto
    Kodama, Michiko
    Hashimoto, Kae
    Mabuchi, Seiji
    Makino, Hiroshi
    Morii, Eiichi
    Yamaguchi, Yoichi
    Yanase, Takeshi
    Itai, Akiko
    Morishige, Ken-ichirou
    Kimura, Tadashi
    ONCOTARGET, 2017, 8 (52): : 89887 - 89902